You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 19, October 22, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (43)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Diabetes Mellitus
 •Review
 •Alert me on articles by topic

Continuous Subcutaneous Insulin Infusion

A Comprehensive Review of Insulin Pump Therapy

M. James Lenhard, MD; Grafton D. Reeves, MD

Arch Intern Med. 2001;161:2293-2300.

A tremendous amount of data suggest that near-normal glycemic control prevents or delays complications of diabetes, which has led to a dramatic increase in continuous subcutaneous insulin infusion (CSII) or insulin pump use. In this article, the data supporting CSII in type 1 diabetes is reviewed, and the advantages and disadvantages of CSII are analyzed. In addition, CSII use in specific situations is examined, including during childhood and pregnancy and while exercising. The published articles suggest that CSII provides better glycemic control than does conventional therapy and comparable to or slightly better control than multiple daily injections. The use of CSII may be especially indicated during pregnancy or for preconception care and for diabetes presenting in childhood or adolescence.


From the Diabetes and Metabolic Diseases Center, Section of Endocrinology, Christiana Care Health Services (Dr Lenhard), and the Division of Pediatric Endocrinology, DuPont Hospital for Children (Dr Reeves), Wilmington, Del; and Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pa (Drs Lenhard and Reeves).


RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2001;161(19):2388-2389.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Unexplained Hyperglycemia in Continuous Subcutaneous Insulin Infusion: Evaluation and Treatment
Ponder et al.
The Diabetes Educator 2008;34:327-333.
ABSTRACT | FULL TEXT  

Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
Nimri et al.
Pediatrics 2006;117:2126-2131.
ABSTRACT | FULL TEXT  

Continuous Subcutaneous Insulin Infusion
Diabetes Care 2004;27:s110-110.
FULL TEXT  

Insulin pumps
Torrance et al.
Arch. Dis. Child. 2003;88:949-953.
FULL TEXT  

Safety and Effectiveness of Insulin Pump Therapy in Children and Adolescents With Type 1 Diabetes
Plotnick et al.
Diabetes Care 2003;26:1142-1146.
ABSTRACT | FULL TEXT  

Nutrient Intake, Glycemic Control, and Body Mass Index in Adolescents Using Continuous Subcutaneous Insulin Infusion and Those Using Traditional Insulin Therapy
Wilson and Smith
The Diabetes Educator 2003;29:230-238.
 

Continuous Subcutaneous Insulin Infusion
Diabetes Care 2003;26:s125-125.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.